Dina Zand's Work on Rare Diseases
Dina Zand is a Medical Officer in the Division of Rare Diseases and Medical Genetics in FDA's Center for Drug Evaluation and Research (CDER). Watch this video to learn more about Dina's work, and register to attend FDA's Rare Disease Day 2021 virtual public meeting to learn more about rare diseases: http://bit.ly/FDARDD2021
Видео Dina Zand's Work on Rare Diseases канала U.S. Food and Drug Administration
Видео Dina Zand's Work on Rare Diseases канала U.S. Food and Drug Administration
Показать
Комментарии отсутствуют
Информация о видео
2 февраля 2021 г. 2:16:34
00:02:55
Другие видео канала
Registration Open: Regulatory Education for Industry (REdI) 2021
Natural History Studies for Rare Diseases
FDA Regulatory Education for Industry (REdI) Annual Conference 2021 - Day 5
Artículos para el consumidor: información sobre la salud y seguridad que necesita
Seminarios virtuales de la FDA y el USDA / FAS para las partes interesadas de la industria
FDA Regulatory Education for Industry (REdI) Annual Conference 2021 - Day 1
FDA Regulatory Education for Industry (REdI) Annual Conference 2021 - Day 4
In Vitro and In Vivo BE Approaches: Challenges and Opportunities – Session 3A
FDA Regulatory Education for Industry (REdI) Annual Conference 2021 - Day 2
Seminarios web de divulgación de la FDA y el USDA / FAS para las partes interesadas de la industria
FDA Regulatory Education for Industry (REdI) Annual Conference 2021 - Day 3
Vaccines and Related Biological Products Advisory Committee - 12/10/2020
CDER’s Office of Pharmaceutical Quality’s Use of Remote Interactive Evaluations
COVID 19 Vaccines: Safety and Diversity Navajo
July 15, 2021 Meeting of the Cardiovascular and Renal Drugs Advisory Committee Meeting
Seminarios virtuales de la FDA y el USDA / FAS para las partes interesadas de la industria
Current Issues in the Safety and Labeling of Cosmetics
CDER’s Office of Compliance's Use of Remote Interactive Evaluation
Director of FDA's CBER, Peter Marks, M.D., Ph.D. on COVID-19 Vaccine Confidence